In the pharmaceutical industry, Gliclazide 80 mg is a second-generation sulfonylurea antidiabetic agent. As a pharmacist, I characterize Gliclazide as a “preferred” sulfonylurea because it offers a lower risk of hypoglycemia and weight gain compared to older agents like Glibenclamide, making it a staple in long-term metabolic management.
Primary Clinical Use
Type 2 Diabetes Mellitus (T2DM): It is indicated for the control of blood glucose in adults when dietary modifications, physical exercise, and weight reduction alone are not sufficient. It is often used as a second-line therapy after Metformin or as a component of dual/triple therapy.
Mechanism of Action
Gliclazide is an insulin secretagogue. It acts primarily by stimulating the beta cells of the pancreas to release more insulin.
Binding to SUR1: It binds to specific sulfonylurea receptors (SUR1) on the surface of pancreatic beta cells.
ATP-sensitive Potassium Channel Closure: This binding causes the closure of potassium channels, leading to cell depolarization.
Insulin Secretion: Depolarization opens voltage-gated calcium channels; the resulting influx of calcium triggers the exocytosis (release) of insulin into the bloodstream.
Extrapancreatic Effects: It also improves peripheral insulin sensitivity and reduces glucose output from the liver.
The Manufacturer’s Perspective: Formulation & Export
From a manufacturing and global trade standpoint, Gliclazide 80 mg is a high-demand, high-precision product:
Immediate Release (IR) vs. Sustained Release (SR): The 80 mg strength is typically the Immediate Release format. As a WHO-GMP manufacturer, we ensure the disintegration time is tightly controlled to provide a rapid post-prandial (after-meal) insulin spike.
Hemovascular Properties: Unique to Gliclazide is its ability to reduce microthrombosis (small blood clots) by inhibiting platelet aggregation. As a firm owner, you can market this “extra” benefit to B2B buyers focused on preventing diabetic complications like retinopathy.
Stability for Global Trade: Gliclazide is stable, but we utilize Alu-Alu or high-grade PVC/PVDC blister packaging to ensure a 36-month shelf life for export to Zone IVb climates (Africa, SE Asia, and the Middle East).
Dossier & Registration: Our Mumbai-based facility provides full CTD/eCTD Dossiers and comparative dissolution data against the innovator (Diamicron) to facilitate registration for our international B2B partners.